Skip to main content
Clinical Trials/NCT03061448
NCT03061448CompletedNot Applicable

Internet-based Exposure Therapy for Panic Disorder: A Randomized Controlled Pilot Study

Karolinska Institutet2 sites in 1 country61 target enrollmentStarted: February 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
61
Locations
2
Primary Endpoint
Panic Disorder Severity Scale - Self rated (PDSS-SR)

Study Overview

Brief Summary

The purpose of this study is examine if an internet-based exposure therapy based on inhibitory learning is feasible, acceptable and effective in reducing panic symptoms amongst patients who suffer from panic disorder and agoraphobia.

Detailed Description

Trial objectives: Primary objective is to examine if an internet-based exposure therapy based on inhibitory learning is effective in reducing panic symptoms. The secondary objective is to study if the protocol is feasible and acceptable. Secondary objective is measured is examined on 1) number of participants completing the study protocol, 2) participants' satisfaction with the treatment, 3) therapists' ratings of acceptability. The aim of this study is to assess the feasibility, and pilot the design and delivery of a RCT that will subsequently form the framework for a larger RCT to evaluate the effectiveness of an exposure protocol based on inhibitory learning.

Trial Design: Randomized controlled pilot study with two groups randomly assigned to either Internet-based exposure therapy based on the principles of inhibitory learning or Internet-based exposure therapy based on the principles of habituation Duration: Eight weeks Primary Endpoint: Change in panic symptoms from baseline to Week 8. Efficacy Parameters: Panic Disorder Severity Scale - Self rated (PDSS-SR) Safety Parameters: Adverse Events is assessed weekly via the internet. Description of Trial Subjects: Patients > 18 years old with a PDSS-SR score more than 6 points Number of Subjects: 80

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Outpatients
  • ≥ 18 years
  • Situated in Sweden
  • Informed consent
  • Panic Disorder Severity Scale - self rated score more than 6 points

Exclusion Criteria

  • Substance dependence during the last six months
  • Post traumatic stress disorder, bipolar disorder or psychosis
  • Symptoms better explained by axis 2 diagnosis (e.g. autism or borderline personality disorder)
  • MADRS-S score above 25 points
  • Psychotropic medication changes within one months prior to treatment that could affect target symptoms.
  • Received exposure based Cognitive behavior therapy (CBT) for pathological worry the last 2 years

Arms & Interventions

Inhibitory learning based treatment

Experimental

The experimental group will go through Internet-based treatment. The exposure treatment is 8 weeks long and based on the principles of inhibitory learning, i.e. the participant is instructed to stay in the frightening situation until his/her expectancy has been maximally violated.

Intervention: Internet-based cognitive-behavior therapy (Behavioral)

Habituation based treatment

Active Comparator

The active comparator group will also go through Internet-based treatment. The exposure treatment is 8 weeks long and based on the principles of emotional processing theory, i.e. the participant is instructed to stay in the frightening situation until anxiety has declined (habituated).

Intervention: Internet-based cognitive-behavior therapy (Behavioral)

Outcomes

Primary Outcomes

Panic Disorder Severity Scale - Self rated (PDSS-SR)

Time Frame: Week 0, Week 8

Change in panic symptoms from baseline to Week 8

Secondary Outcomes

  • Client Satisfaction Questionnaire (CSQ)(Week 8)
  • Anxiety Sensitivity Index (ASI)(Week 0, Week 8)
  • Patient Health Questionnaire (PHQ-9)(Week 0, Week 8)
  • HA-NI-SSD Symptom Preoccupation Scale - testversion (SPSt)(Week 0, Week 8)
  • Body Sensations Questionnaire (BSQ)(Week 0, Week 8)
  • WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)(Week 0, Week 8)
  • Adverse events scale(Week 8)
  • Credibility/Expectancy Questionnaire (CEQ)(Week 2)
  • Brunnsviken Quality of Life Questionnaire (BBQ)(Week 0, Week 8)
  • Agoraphobic Cognitions Questionnaire (ACQ)(Week 0, Week 8)
  • Generalised Anxiety Disorder Assessment (GAD-7)(Week 0, Week 8)
  • The Cardiac Anxiety Questionnaire (CAQ)(Week 0, Week 8)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Erik Andersson

PhD, psychologist

Karolinska Institutet

Study Sites (2)

Loading locations...

Similar Trials